4.7 (590) In stock
International application publshed with declaration under Article 17 (2) (a)
US20170360960A1 - AAV Vectors Targeted to the Central Nervous System - Google Patents
WO2015095811A2 - Combination therapy with neoantigen vaccine - Google Patents
WO2015095811A2 - Combination therapy with neoantigen vaccine - Google Patents
US20170360960A1 - AAV Vectors Targeted to the Central Nervous System - Google Patents
WO2005013901A2 - Oligomeric compounds and compositions for use in modulation of small non-coding rnas - Google Patents
WO2016207858A1 - Factor xi antibodies and methods of use - Google Patents
WO2007062852A2 - ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND
US20210163929A1 - Methods and compositions for the treatment of hepatic and metabolic diseases - Google Patents
US20160076054A1 - Effective delivery of large genes by dual aav vectors - Google Patents
WO2017189964A2 - Compositions for the treatment of disease - Google Patents
EP3385870A1 - Immunoglobulins with reduced aggregation - Google Patents
US20160076054A1 - Effective delivery of large genes by dual aav vectors - Google Patents
